192 related articles for article (PubMed ID: 24981774)
1. Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs.
Hu J; Liu J; Narayanannair KJ; Lackey JG; Kuchimanchi S; Rajeev KG; Manoharan M; Swayze EE; Lima WF; Prakash TP; Xiang Q; Martinez C; Corey DR
Biochemistry; 2014 Jul; 53(28):4510-8. PubMed ID: 24981774
[TBL] [Abstract][Full Text] [Related]
2. Allele-selective inhibition of expression of huntingtin and ataxin-3 by RNA duplexes containing unlocked nucleic acid substitutions.
Aiba Y; Hu J; Liu J; Xiang Q; Martinez C; Corey DR
Biochemistry; 2013 Dec; 52(51):9329-38. PubMed ID: 24266403
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway.
Hu J; Liu J; Yu D; Chu Y; Corey DR
Nucleic Acids Res; 2012 Dec; 40(22):11270-80. PubMed ID: 23042244
[TBL] [Abstract][Full Text] [Related]
4. Targeting several CAG expansion diseases by a single antisense oligonucleotide.
Evers MM; Pepers BA; van Deutekom JC; Mulders SA; den Dunnen JT; Aartsma-Rus A; van Ommen GJ; van Roon-Mom WM
PLoS One; 2011; 6(9):e24308. PubMed ID: 21909428
[TBL] [Abstract][Full Text] [Related]
5. Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs.
Hu J; Gagnon KT; Liu J; Watts JK; Syeda-Nawaz J; Bennett CF; Swayze EE; Randolph J; Chattopadhyaya J; Corey DR
Biol Chem; 2011 Apr; 392(4):315-25. PubMed ID: 21294677
[TBL] [Abstract][Full Text] [Related]
6. Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs.
Hu J; Matsui M; Gagnon KT; Schwartz JC; Gabillet S; Arar K; Wu J; Bezprozvanny I; Corey DR
Nat Biotechnol; 2009 May; 27(5):478-84. PubMed ID: 19412185
[TBL] [Abstract][Full Text] [Related]
7. RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression.
Liu J; Pendergraff H; Narayanannair KJ; Lackey JG; Kuchimanchi S; Rajeev KG; Manoharan M; Hu J; Corey DR
Nucleic Acids Res; 2013 Oct; 41(18):8788-801. PubMed ID: 23887934
[TBL] [Abstract][Full Text] [Related]
8. Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.
Hu J; Liu J; Corey DR
Chem Biol; 2010 Nov; 17(11):1183-8. PubMed ID: 21095568
[TBL] [Abstract][Full Text] [Related]
9. ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy.
Liu J; Yu D; Aiba Y; Pendergraff H; Swayze EE; Lima WF; Hu J; Prakash TP; Corey DR
Nucleic Acids Res; 2013 Nov; 41(20):9570-83. PubMed ID: 23935115
[TBL] [Abstract][Full Text] [Related]
10. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.
Gagnon KT; Pendergraff HM; Deleavey GF; Swayze EE; Potier P; Randolph J; Roesch EB; Chattopadhyaya J; Damha MJ; Bennett CF; Montaillier C; Lemaitre M; Corey DR
Biochemistry; 2010 Nov; 49(47):10166-78. PubMed ID: 21028906
[TBL] [Abstract][Full Text] [Related]
11. Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs.
Hu J; Liu J; Yu D; Aiba Y; Lee S; Pendergraff H; Boubaker J; Artates JW; Lagier-Tourenne C; Lima WF; Swayze EE; Prakash TP; Corey DR
Nucleic Acid Ther; 2014 Jun; 24(3):199-209. PubMed ID: 24694346
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats.
Fiszer A; Mykowska A; Krzyzosiak WJ
Nucleic Acids Res; 2011 Jul; 39(13):5578-85. PubMed ID: 21427085
[TBL] [Abstract][Full Text] [Related]
13. Limits of using oligonucleotides for allele-selective inhibition at trinucleotide repeat sequences - targeting the CAG repeat within ataxin-1.
Hu J; Corey DR
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):185-194. PubMed ID: 31645175
[TBL] [Abstract][Full Text] [Related]
14. Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.
Luthi-Carter R; Strand AD; Hanson SA; Kooperberg C; Schilling G; La Spada AR; Merry DE; Young AB; Ross CA; Borchelt DR; Olson JM
Hum Mol Genet; 2002 Aug; 11(17):1927-37. PubMed ID: 12165555
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases.
Fiszer A; Olejniczak M; Switonski PM; Wroblewska JP; Wisniewska-Kruk J; Mykowska A; Krzyzosiak WJ
BMC Mol Biol; 2012 Mar; 13():6. PubMed ID: 22397573
[TBL] [Abstract][Full Text] [Related]
16. FAT10 protein binds to polyglutamine proteins and modulates their solubility.
Nagashima Y; Kowa H; Tsuji S; Iwata A
J Biol Chem; 2011 Aug; 286(34):29594-600. PubMed ID: 21757738
[TBL] [Abstract][Full Text] [Related]
17. Silencing of genes responsible for polyQ diseases using chemically modified single-stranded siRNAs.
Fiszer A; Ellison-Klimontowicz ME; Krzyzosiak WJ
Acta Biochim Pol; 2016; 63(4):759-764. PubMed ID: 27770571
[TBL] [Abstract][Full Text] [Related]
18. Atrophin-1 Function and Dysfunction in Dentatorubral-Pallidoluysian Atrophy.
Nowak B; Kozlowska E; Pawlik W; Fiszer A
Mov Disord; 2023 Apr; 38(4):526-536. PubMed ID: 36809552
[TBL] [Abstract][Full Text] [Related]
19. Universal RNAi Triggers for the Specific Inhibition of Mutant Huntingtin, Atrophin-1, Ataxin-3, and Ataxin-7 Expression.
Kotowska-Zimmer A; Ostrovska Y; Olejniczak M
Mol Ther Nucleic Acids; 2020 Mar; 19():562-571. PubMed ID: 31927329
[TBL] [Abstract][Full Text] [Related]
20. Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease models.
Joachimiak P; Ciesiołka A; Kozłowska E; Świtoński PM; Figura G; Ciołak A; Adamek G; Surdyka M; Kalinowska-Pośka Ż; Figiel M; Caron NS; Hayden MR; Fiszer A
BMC Biol; 2023 Feb; 21(1):17. PubMed ID: 36726088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
